Brand name authorized in: United Kingdom
The drug ADCAL-D3 contains a combination of these active pharmaceutical ingredients (APIs):
In its biologically active form vitamin D3 stimulates intestinal calcium absorption, incorporation of calcium into the osteoid, and release of calcium from bone tissue. In the small intestine it promotes rapid and delayed calcium uptake. The passive and active transport of phosphate is also stimulated.
This drug has been assigned below unique identifiers within the countries it is being marketed: